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Background: The proven benefit of integrating cervical cancer screening programme into HIV care has led to its
adoption as a standard of care. However this is not operational in most HIV clinics in Nigeria. Of the various reasons
given for non-implementation, none is backed by scientific evidence. This study was conducted to assess the
willingness and acceptability of cervical cancer screening among HIV positive Nigerian women.
Methods: A cross sectional study of HIV positive women attending a large HIV treatment centre in Lagos, Nigeria.
Respondents were identified using stratified sampling method. A pretested questionnaire was used to obtain
information by trained research assistants. Obtained information were coded and managed using SPSS for windows
version 19. Multivariate logistic regression model was used to determine independent predictor for acceptance of
cervical cancer screening.
Results: Of the 1517 respondents that returned completed questionnaires, 853 (56.2%) were aware of cervical
cancer. Though previous cervical cancer screening was low at 9.4%, 79.8% (1210) accepted to take the test. Cost of
the test (35.2%) and religious denial (14.0%) were the most common reasons given for refusal to take the test.
After controlling for confounding variables in a multivariate logistic regression model, having a tertiary education
(OR = 1.4; 95% CI: 1.03-1.84), no living child (OR: 1.5; 95% CI: 1.1-2.0), recent HIV diagnosis (OR: 1.5; 95% CI: 1.1-2.0)
and being aware of cervical cancer (OR: 1.5; 95% CI: 1.2-2.0) retained independent association with acceptance to
screen for cervical cancer.
Conclusions: The study shows that HIV positive women in our environment are willing to screen for cervical
cancer and that the integration of reproductive health service into existing HIV programmes will strengthen rather
than disrupt the services.
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Each year about half a million women develop invasive
cancer of the uterine cervix, with more than 80% occur-
ring in low income countries [1,2]. A majority of the
cases presents in late stages when available treatments
are ineffective [1,3]. The scenario is entirely different in
high-income countries where cervical cancer has almost
been eliminated as a result of efficient cervical cancer
prevention programmes [1,4].
In sub Saharan African countries where cervical can-
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reproduction in any medium, provided the orleading causes of death in women [5], making the inter-
actions between the diseases a major public health chal-
lenge [6]. The risk of developing cervical cancer and
increased aggressiveness of existing cervical cancer has
been reported in HIV infected women [7,8]. Integrating
cervical cancer prevention within HIV care services will
not only decrease the morbidity and mortality associated
with invasive cervical cancer but will also improve HIV
treatment outcomes [5,7,8]. Investigators in Zambia in a
report of the evaluation of the success of their integra-
tion of cervical cancer prevention services into existing
HIV care services concluded that the model be adopted
as an implementation platform low-cost cervical cancer
prevention [9].Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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recognizing the potential benefit of cervical cancer pre-
vention in HIV infected women, recommended the
introduction of cervical cancer screening within HIV
programmes as a standard of care [10]. Unfortunately,
this important recommendation is not yet operational in
most HIV clinics, either as a result of lack of will to do
so or for the fear of possible disruption of the successful
HIV services [1,8,11,12]. The latter reason is not backed
by scientific evidence, as the only published study from
Nigeria on the subject in women of known HIV positive
status showed a 96.0% ‘willingness to screen’ in future
[13]. However this study was among women who have
just completed posttest counseling and not yet enrolled
into HIV care, making it difficult to use the information
to extrapolate what the situation would be in HIV care
and treatment setting. In addition, varying refusal rates
have been reported from other high HIV prevalent
countries ranging from 12-87% [14-17]. Determining the
cervical cancer screening refusal rates among HIV posi-
tive Nigerians already in HIV care is therefore necessary
as it will not only be useful for the refinement of pro-
grammes but as an advocacy tool.
This study was therefore conducted to determine
the acceptability of cervical cancer screening among
HIV infected women using a sample population that
is sufficiently powered to make generalization pos-
sible. In addition, the predictors of acceptance of cer-
vical cancer screening among these women were also
determined. Information obtained will be used to
fine-tune the integration of cervical cancer screening
process, which is ongoing in our HIV treatment
centre and hopefully in similar clinics in Nigeria and
elsewhere.
Methods
Study design and setting
The study was a cross-sectional survey conducted at the
HIV treatment centre, Nigerian Institute of Medical Re-
search (NIMR), Lagos. NIMR is the apex medical research
institution in Nigeria charged with the responsibility to
conduct research into disease of public health importance
in the Country. However following the initiation of the
Federal Government of Nigeria antiretroviral drug access
programme in 2002, it was selected as one of the 25 cen-
tres. It was selected principally to meet the research com-
ponent of the programme. The centre currently provides
comprehensive HIV care, treatment and support for over
18,000 patients (64.6% are women). Sixty five percent of
the patients come from Lagos and the rest from the other
5 states of southwestern Nigeria, North-central, South-
south and South-eastern Nigeria. A little over 0.025%
comes from the neigbouring western African countries.
The services at the centre are provided free to the patients.Study population
Adult females aged 18 years and older seen at the centre
for their monthly antiretroviral drug refill, 3-6monthly
physician appointment or for registration into HIV care
from 1st to 30th of April 2011.
Study sample size determination
The sample size for the study was determined using Rao-
soft sample size calculator (http://www.raosoft.com/
samplesize.html) [18]. Given that there were approximately
9,000 women who are current on the programme, on the
basis of the most conservative response distribution of 50%,
allowing 2.5% margin of error at 95% confidence interval,
the required sample size was calculated to be 1313. The
sample size was increased by 15% in anticipation of non-
response as in a previous study in the centre. A final mini-
mum sample size of 1510 was obtained.
Study sample selection
Participants were approached for the interview after
selection from the lists of attendance using propor-
tionate stratified sampling method. This is to enable
generalization of the findings of the study to the women
at the clinic. Each of the patient’s categories in the clinic
of drug refill, 3-6monthly physician consult and new
patients were considered to be a homogenous popula-
tion. These three categories were often in the ratio of 50:
25:1 at each clinic day. Daily list of clinic attendee was
categorized into the three groups above with each serv-
ing as a frame. Respondents were then selected from the
frames by simple random sampling using the ratio of
50:25:1.
Those who accepted to participate and signed an
informed consent form were recruited.
Informed consent process
Information on cervical cancer and cervical cancer screen-
ing were given to the women who were selected from the
sample frame by research assistants as part of the
informed consent process before signing the consent form.
The study questionnaires were administered thereafter.
Data collection
A semi structured questionnaire containing both closed
and open ended questions specifically designed for the
study was used for data collection. The questionnaire was
pretested among 25 patients for comprehensibility, appro-
priateness of language, sensitivity of questions and average
duration of administration. The feedback received after
this process was used to modify and finalize the study
questionnaire.
Information on sociodemographic characteristics, know-
ledge about cervical cancer, cervical cancer screening,
previous screening history and personal perception of risk
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dents who consented to be in the study. The question-
naire further enquired the willingness of the women
to accept cervical cancer screening if offered. Those
who showed willingness were asked to register their
names with a trained counselor as indication of ac-
ceptance. The questionnaires were administered in
English by trained research assistants. For low litera-
tes, the interview was conducted in their local dialect




The women’s age at their last birth day.
 Tribal group
The women were asked to state their tribe of origin.
However during analysis the minority tribes in north
and south were coded together because of their
socio-cultural similarities and their small numbers.
 Religion
The two commonest religions in the country,
Christianity and Islam were listed and non
Christians and non Moslems were asked to mark
others and specify their religion thereafter.
 Educational level completed
The women were asked to choose from options of
from none, primary, secondary and tertiary.
 Marital status
Was determined by the question: How will you
identify your marital status? Options listed were:
Married, Not married and Widow.
 Living children
Was determined by the question: How many of your
children are alive? They were expected to write the
exact number of their children currently alive. However
during analysis this response was dichotomized into
two of Yes and No, where Yes denotes having at least
one child alive and No denotes none.
 Duration of HIV disease
Respondents were asked to state the number of
months elapsed since they were diagnosed HIV
positive. This was dichotomized to ≤12 months, 13–
36 months and >36 months.
 Awareness of cervical cancer and testing
Refers to an affirmative answer to two questions; 1.
Have you heard of cervical cancer? 2. Are you aware
of the test used to screen for cervical cancer?, and in
addition explained in their own language what they
know about them.
 Ever tested for cervical cancer
The women were asked whether they ever had tested
for cancer of the cervix. The options were Yes or No. Self-risk assessment
Respondents were asked to assess their level of risk
of having cervical cancer. They were expected to
choose the alternatives; high, low or none.
 Willingness to screening for cervical cancer
Refers to women who answered Yes to the question
“Do you want to be screened for cervical cancer “in
the study questionnaire.
 Acceptance to screen for cervical cancer in future
Refers to women who answered yes to the question
“Do you want to be screened for cervical cancer
“and in addition registered their name with the
counselor for screening. However respondent who
were not willing to screen initially but eventually
registered their name with counselor were re-
categorized into the group of “ future acceptance of
cervical cancer screening” group.
Data analysis
The obtained information were coded, entered into the
computer and analyzed using the SPSS version 19.0
(SPSS Inc. Chicago, IL) statistical packages. The main
outcome variable was acceptance of cervical cancer
screening. Univariate analysis using the Chi-square stat-
istic was performed to identify factors associated with
the acceptance of cervical cancer screening. Multivariate
logistic regression was used to identify independent fac-
tors for acceptance of cervical cancer screening. Vari-
ables were entered into the model if their P value on
univariate analysis was 0.25 or less. Odds ratio (OR) or
adjusted OR (AOR) and their 95% confidence intervals
(CI) were used to measure strength of associations. A
P-value (two-tailed test) of <0.05 was considered signifi-
cant. Acceptability rate was calculated as the number of
women who accepted to screen out of the number of
women who participated in the study.
Ethical issues
Approval for the study was obtained from the Institutional
Review Board, Nigerian Institute of Medical Research,
Lagos Nigeria. Written informed consent was obtained
from all women, before interview. The women were
approached after the receipt of care so as to ensure that
they were not coerced into the study. The clinic patients
are organized into an independent support group of
people living with HIV (Positive Life Organization of
Nigeria) that ensures that patient’s rights are not violated.
Results
A total 1675 women were invited to participate in the
study; of which 1558 accepted and received the ques-
tionnaire. Forty-one of these were either not returned or
returned uncompleted (response rate of 90.6%; 1517).
Table 1 The Sociodemographic characteristics of the
respondents, Lagos, Nigeria April 2011 (n = 1517)
Sociodemographic characteristics Number of respondents (%)
Age (Years)
 Less than 20 16(1.1)
 20 – 29 316(20.8)
 30 – 39 797(52.5)
 40 – 49 341(22.5)













 Southern Minority 224(14.7)







Number of Living Children
 0 – 1 764(50.4)
 2 – 4 675(44.5)
 5 and above 78(5.1)
Duration of HIV disease (Months)
 Less than 13 417(27.5)
 13 – 36 422(27.8)
 Greater than 36 678(44.7)
HIV risk of transmission
 Heterosexual Contact 1208(79.6)
 Blood and Blood product 233(15.4)
 Others 78(5.0)
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Table 1 shows the sociodemographic characteristics of the
1517 respondents that returned completed questionnaires.
Most of the respondents were Christians (56.0%) and
infected through heterosexual contact (79.6%). The mean
age of the women was 31 ± 7 years (range 18–57). The
majority of the respondents were between ages 30 to49 (75.0%). Yoruba (37.1%) and Igbo (37.9%) were the
predominant tribes of the respondents. One thousand
two hundred and fifty seven (82.9%) of 1517 women com-
pleted at least secondary level education, 223(14.7%) com-
pleted primary and 37 (2.4%) women had no formal
education. On the average the respondent had 2 living
children and been diagnosed HIV positive for 39.5 months
(range 0–119 months).Cervical cancer awareness and acceptance of testing
The cervical cancer awareness, self-risk assessment, screen-
ing knowledge and practice is shown in Table 2. Eight hun-
dred and fifty three respondents (56.2%) were aware of
cervical cancer and only 523 (34.5%) respondents were
aware of cervical cancer screening/test. Only 143 (9.4%)
respondents had ever tested for cervical cancer. The major-
ity of the respondents assessed their risk of developing cer-
vical cancer as low (68.2%), however 79.8% (1210)
respondents accepted to take cervical cancer screening/test.Predictive factors for acceptance of testing
To determine predictors of acceptance of cervical cancer
screening, we compared the sociodemographic, cervical
cancer awareness status and self-risk assessment data with
cervical cancer screening acceptance status among the
respondents (Table 3). Differences in accepting to screen
for cervical cancer were found for various variables. At
univariate analysis, a greater percentage of women who
accepted to take the test had more than secondary educa-
tion (OR: 1.4; 95% CI:1.03 -1.84), no living children
(OR:1.5;95% CI:1.06-1.99),diagnosed HIV positive within
one year (OR:1.49;95% CI:1.11-2.02) and were aware of
cervical cancer (OR:1.53;95% CI:1.19-1.96). After control-
ling for potential confounding variables of age, educational
status, duration of HIV diagnosis and awareness of cer-
vical cancer in a multivariate logistic regression model, it
showed that women who had more than secondary educa-
tion were 1.4 times likely to accept to take the test as com-
pared with those who had less than secondary education
(OR = 1.4; 95% CI:1.03-1.84). Respondents who had no liv-
ing children were one and half times more likely to take
the test than their counterparts with living children (OR:
1.5; 95% CI: 1.1-2.0). Women whose HIV diagnosis were
made within one year were one and half times more likely
to take the test than the respondents whose diagnosis
were made over 3 years (OR:1.5; 95% CI:1.1-2.0). The
women who were aware of cervical cancer and cervical
cancer testing were 2 times more likely to take the test
than those who were not aware of the disease and test
(OR:1.5; 95% CI: 1.2-2.0). However, religion, ethnic group-
ing, marital status, self-risk assessment status and previous
cervical cancer screening experience were found not to be
associated with test uptake.
Table 2 Cervical cancer awareness, self-risk assessment,
screening knowledge and practices among HIV infected
Nigerian women Lagos, Nigeria April 2011 (n = 1517)
Variables No of respondents (%)
Aware of cervical cancer?
 Yes 853(56.2)
 No 664(43.8)
Aware of cervical cancer testing?
 Yes 523(34.5)
 No 994(65.5)
Ever Tested for Cervical Cancer?
 Yes 143(9.4)
 No 1374(90.6)
Cervical cancer self-risk assessment
 Low 1034(68.2)
 High 483(31.8)
Acceptance of cervical cancer screening?
 Accepted 1210(79.8)
 Rejected 307(20.2)
Ezechi et al. BMC Public Health 2013, 13:46 Page 5 of 8
http://www.biomedcentral.com/1471-2458/13/46Reasons for non-acceptance of cervical cancer screening
test
Of the 1517 that returned completed questionnaire, 307
(20.2%) did not register their name with the counselor,
indicating that they are not ready to undergo cervical
cancer screening. While (92.5% women of the 307
women that were not ready to be screened for cervical
cancer gave various reasons for their action (See Table 4),
7.5% had no reason. The most common reason for re-
fusal was the anticipated high cost of the test (35.2%).
Other reasons were religious denial (14.0%), the need to
obtain partner’s approval (12.4%), anticipated long wait-
ing time (12.7%), pregnant/recently delivered (10.7%)
and fear of test outcome (4.2%).
Discussion
This study showed a relatively high cervical cancer screen-
ing acceptance rate of 79.8% despite a moderate level of
awareness of cervical cancer and it’s testing among the
HIV positive women. Having a tertiary education, no living
child, recent HIV diagnosis and awareness of cervical can-
cer were found to be associated with acceptance of cervical
cancer screening. The level of awareness of cervical cancer
as a disease (56.2%) and its testing (34.5%) among the
respondents in this study though similar to findings from
some previous studies [12,19,20] is lower than the finding
in two recent studies conducted in our environment in
2009 and 2011 [21,22]. One would have expected that the
present study being among a group at risk for cervical can-
cer, that the awareness level would have been much higher.
Secondly, as our study was conducted after the two most
recent studies [21,22], we were expecting at least a modestincrease on awareness level due to the introduction of cer-
vical cancer programme by the Government of Nigeria. A
plausible reason for the lower awareness in this study could
be the lower educational attainment of the respondent in
this study compared to the studies by Bukar et al [21] and
Dim et al. [22]. Supporting the above assertion of the posi-
tive role of educational attainment to cervical cancer
awareness and test uptake is the finding in this study in
which women with tertiary education were 1.4 times likely
to take the test than women with lower qualification. The
finding also underscores the importance of education in in-
creasing cervical cancer awareness and screening uptake. A
more intensified health education on cervical cancer and
testing should be introduced in our programme and other
HIV programmes in other to increase the awareness of cer-
vical cancer and screening among these at risk group. In
addition, the abysmally low “ever tested for cervical cancer”
response (9.4%) in this study confirms the poor state of
cervical cancer prevention and control in Nigeria. This is
one of the reasons for the unacceptable morbidity and
mortality associated with cervical cancer in Nigeria.
Puzzling, however in this study is the obvious discon-
nect between low awareness of cervical cancer and screen-
ing, high- low self-risk assessment of self to have cervical
cancer (68.2%) and the high test acceptance rate (79.8%)
among the respondents when compared to the acceptance
rate of 44.0% reported by McKenzie et al. among HIV
positive Kenyan women [23]. Although the Kenyan study
restricted their enrollment to only women aged 30–
39 years compared to this study with no age restriction,
the main reason may be the almost absolute trust and re-
lationship that exists between HIV positive clients and
their primary Physician. The daily counseling and health
talk by Counselors and Nurses obviously has a positive
role in the high rate. To further strengthen the cervical
cancer prevention programme, identification of the reason
for the high rate of 79.8% among our cohort calls for an
in-depth study using qualitative research methodology.
The present study apart from determining the level of
awareness and acceptability of cervical cancer screening in
future, determined the risk factors associated with future
cervical cancer test uptake with the aim of using the infor-
mation as counseling and advocacy tool. Awareness of cer-
vical cancer screening and testing was found to be
independently associated with the acceptance of cervical
cancer screening. Respondent who were aware of cervical
cancer as a disease were 1.5 times likely to accept the
screening than those who are not aware. With awareness,
one is likely to know the benefits of the test and thus opts
for it. Awareness and education has been shown to
improve the health seeking behaviour of individuals
as it relates to uptake of cervical cancer services in-
cluding testing [21-24]. The finding of respondents
with tertiary education being 1.4 times likely to take
Table 3 Association between acceptance of cervical cancer screening, sociodemographic status of the respondents,
cervical cancer awareness, self-risk assessment and history of previous cervical cancer screening (n = 1517)
Variables Accepted cervical cancer screening 95% CI
Crude OR
95% CI
Adjusted ORYes (%) No (%)
Age (years)
 Less than 25 54(4.5) 12(3.9) 0.89(0.46-1.71) 0.87(0.46-1.68)
 25-34 572(47.3) 149(48.5) 1 (ref) 1 (ref)
 ≥ 35 584(48.2) 146(47.6) 1.04(0.81-1.35) 1.04(0.80-1.34)
Tribal Group
 Yoruba 414(34.2) 109(35.5) 1.01(0.84-1.48) 1.10(0.49-2.48)
 Igbo 505(41.7) 127(41.4) 1 (ref) 1 (ref)
 Northern Tribes 113(9.3) 23(7.5) 0.97(0.66-1.40) 0.97(0.67-1.42)
 Southern Minority Tribes 176(14.5) 46(15.0) 0.71(0.36-1.40) 0.78(0.29-2.08)
Religion
 Christianity 676(55.9) 173(56.4) 1 (ref) 1 (ref)
 Islam 532(44.0) 132(43.0) 0.99(0.77-1.27) 0.93(0.68-1.28)
 Others 3(0.1) 1(0.3)
Educational level completed
 Less than Secondary 206(17.0) 54(17.6) 1.31(0.87-1.87) 1.20(0.83-1.80)
 Secondary 605(50.0) 171(55.7) 1 (ref) 1 (ref)
 Greater than Secondary 399(33.0) 82(26.7) 1.43(1.03-1.84) 1.31(1.02-1.83)a
Marital status
 Married 725(59.9) 198(64.5) 1 (ref) 1 (ref)
 Not married 485(40.1) 109(35.5) 0.82(0.63-1.07) 0.90(0.68-1.18)
Living children
 Yes 875(72.3) 243(79.2) 1 (ref) 1 (ref)
 No 335(27.7) 64(20.8) 1.45(1.06-1.99) 1.62(1.31-1.89) b
Duration of HIV disease
 <13 months 318(26.3) 99(32.2) 1.49(1.11-2.02) 1.50(1.1-1.98)c
 13-36 months 331(27.4) 91(29.6) 1 (ref) 1 (ref)
 ≥13 months 561(46.4) 1179(38.1) 1.32(0.97-1.79) 1.31(0.97-1.78)
Aware of cervical cancer
 Yes 706(58.3) 147(47.9) 1.53(1.19-1.96) 1.49(1.15-1.95)d
 No 504(41.7) 160(52.1) 1 (ref) 1 (ref)
Ever tested for cervical cancer
 Yes 118(9.8) 25(8.1) 1.22(0.78-1.91) 1.23(0.71-1.22)
 No 1092(90.2) 282(91.9) 1 (ref) 1 (ref)
Self-risk assessment of cervical cancer
 High 381(31.5) 102(33.2) 1 (ref) 1 (ref)
 Low 829(68.5) 205(66.8) 1.08(0.82-1.43) 1.10(0.93-1.39)
 None 0(0.00) 0(0.00)
Note: Potential confounders adjusted at multivariate logistic regression analysis.
a. Adjusted for age, time elapsed since HIV diagnosis and awareness of cervical cancer.
b. Adjusted for age, marital status and time elapsed since HIV diagnosis.
c. Adjusted for age, educational status, and awareness of cervical cancer.
d. Adjusted for age, educational status and time elapsed since HIV diagnosis.
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tional attainment support the above assertion. Educa-
tional attainment has been shown to be associated
with acceptance of reproductive services and this is
not only linked to women’s empowerment of makingdecision but ability to pay for these services without
recourse to their partners [22]. Education is also
linked with patient's self-perception of cervical cancer
and understanding health education and counseling
that goes on with it [21].
Table 4 Reason for non-acceptance of cervical cancer
screening among the respondents
Reason n(%)
Cost of test related issues 108(35.2)
Religious denial 43(14.0)
Requires partners permission 38(12.4)
Time to take the test/ long waiting time 39(12.7)
“Am pregnant/Recently delivered” 33(10.7)
“Am afraid to take the test” 13(4.2)
Taken the test before 9(2.9)
Had surgery of the vulva 1(0.3)
No reason 23(7.5)
Total 307(100.0)
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who are relatively new in our programme are almost 2
times more likely to accept screening than women who
have been in the programme for a longer time. Though
the other previous studies did not evaluate this variable,
making it difficult for comparison, evidence has shown
that health seeking behaviour of individuals are better dur-
ing symptomatic illness than if there is no symptom [25].
Also as opportunistic illness disappears and quality of life
improves with antiretroviral therapy, other life events be-
come more important than performance of test that the
usefulness is not immediately obvious. Health education
and counseling among HIV positives should therefore in-
crease rather than decrease as the client’s health get better.
The cervical cancer test acceptance in this study was
found to be 1.5 times higher in respondent who do not
have any living child compared to their peers with living
children. The higher acceptance rate among the respon-
dents with no living children may be due to their expected
better knowledge as a result of their higher educational at-
tainment. It is therefore expected that well-educated and
knowledgeable persons will opt for a healthier life style of
cervical cancer screening.
In as much as one may be tempted to accept the accept-
ance rate of 79.8% as good, looking at the other side of the
flip- a refusal rate of 20.2% is unacceptably high especially
for a lethal illness among a group of person at increased
risk for the disease. If we must reduce the morbidity and
mortality associated with cervical cancer, we should re-
duce the refusal rate to single digit if not to 0%. With the
reduction of refusal rate in mind, we determined the rea-
sons for test refusal among the respondents. The antici-
pated cost of testing (35.2%), religious denial (14.0%), need
to obtain partners’ permission (12.4%) and long waiting
time (12.7%) were found to be main reasons for non-
acceptance of the test (see Table 4). It is rather surprising
that respondents attributed cost as the major reason for
their refusal to take the test, as cervical cancer screeningis free at the centre. The obvious explanation might be
that either they are unaware that it is free just like other
HIV services or the cost they referred to may be cost
related to transportation and loss of revenue as a result of
having to spend almost a whole day at the clinic. Support-
ing the last reason is the fact that long waiting time was
also a common reason for refusal. While transport cost
can be reduced by taking services closer to client homes,
it could also lead to decentralization and reduction in
waiting time. Tasks shifting is the ultimate strategy to solv-
ing the challenge of long waiting time at the clinic. Evi-
dence has consistently shown that delegation of tasks,
whether from doctors to non-physician health workers es-
pecially the midwives can lead to improvement in access,
coverage and quality of health services at comparable or
lower cost than traditional delivery models [14,15,26]. In
addition, it will reduce the workload on the physicians
who are already overwhelmed from providing HIV ser-
vices. We have successfully task shifted some HIV services
to other health care workers and thus task shifting cervical
cancer screening will build on the existing task shifting
model. In addition, scheduling the cervical cancer screen-
ing during routine HIV clinic consults and drug refill will
ensure that all the women who want to be tested do not
spend extra days and time accessing this service. This will
ultimately increase the acceptance rate. The other reasons
for refusal ‘need partner’s permission’ and religious denials
should be addressed urgently. The government through
advocacy and possibly legislation needs to urgently ad-
dress the encroachment of the religious miscreants into
health without providing health infrastructure like the
traditional mission hospitals. This encroachment has dire
consequences as the poor and vulnerable groups now be-
lieve these men to a higher extent than the health care
workers [16]. It is therefore not a surprise finding in this
study that the second most common reason for refusal of
the test was related to client’s religious belief and teaching.
Some clients think that they cannot actually have cervical
cancer because of their religious belief. This belief is as a
result of activities of some religious leaders that diseases
are only from the devil and children of God do not have
diseases [16,17].
Low status of women and lack of autonomy in taking
decisions should be seriously addressed. The current
situation where a significant number of women cannot
take decision whether to participate in a lifesaving test
as a result of sociocultural and religious impediment is
regrettable. Government of Nigerian and Ministry of
Women Affairs in particular should focus on it and
bring it to the front burner.
A possible limitation of the study was possible biased
answers from the patient to please researchers who are
their primary care provider. This could have overesti-
mated the acceptance rate of cervical cancer test. We
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tering the questionnaire to the patients after they had
completed their routine HIV care for the day. In addition
the questionnaire and informed consent process were
administered by peer counselors who are HIV positives
and members of the clinic support group.
Finally, it is important to state that educating women
on the importance of cervical cancer screening and pro-
viding cervical cancer screening services is just not
enough. Even more important is the provision of access-
ible and affordable treatment services. Government of
Nigeria at all levels are urged not stop at creating aware-
ness and screening services, but endavour to provide af-
fordable and accessible treatment services.
Conclusion
The study shows that HIV positive women in our centre are
willing to be screened for cervical cancer and thus service
integration will only strengthen rather than disrupt the exist-
ing HIV services. The refusals as a result of anticipated cost,
long waiting time and spousal approval need to be urgently
addressed through advocacy and public enlightenment.
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